Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab

Summary

The purpose of this study is to determine if denosumab is effective in the treatment of relapsed or plateau-phase multiple myeloma.

Timeline

Start

2005-11

Primary completion

2007-08

Completion

2011-12

Publications

• Background Vij R, Horvath N, Spencer A, Taylor K, Vadhan-Raj S, Vescio R, Smith J, Qian Y, Yeh H, Jun S. An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma. Am J Hematol. 2009 Oct;84(10):650-6. doi: 10.1002/ajh.21509.

Drugs

Indications